Cross-Talk between Obesity and Diabetes: Introducing Polyphenols as an Effective Phytomedicine to Combat the Dual Sword Diabesity.


Journal

Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487

Informations de publication

Date de publication:
2022
Historique:
received: 25 10 2021
accepted: 06 02 2022
pubmed: 29 6 2022
medline: 19 8 2022
entrez: 28 6 2022
Statut: ppublish

Résumé

Obesity-associated diabetes mellitus, a chronic metabolic affliction accounting for 90% of all diabetic patients, has been affecting humanity extremely badly and escalating the risk of developing other serious disorders. It is observed that 0.4 billion people globally have diabetes, whose major cause is obesity. Currently, innumerable synthetic drugs like alogliptin and rosiglitazone are being used to get through diabetes, but they have certain complications, restrictions with severe side effects, and toxicity issues. Recently, the frequency of plant-derived phytochemicals as advantageous substitutes against diabesity is increasing progressively due to their unparalleled benefit of producing less side effects and toxicity. Of these phytochemicals, dietary polyphenols have been accepted as potent agents against the dual sword "diabesity". These polyphenols target certain genes and molecular pathways through dual mechanisms such as adiponectin upregulation, cannabinoid receptor antagonism, free fatty acid oxidation, ghrelin antagonism, glucocorticoid inhibition, sodium-glucose cotransporter inhibition, oxidative stress and inflammation inhibition etc. which sequentially help to combat both diabetes and obesity. In this review, we have summarized the most beneficial natural polyphenols along with their complex molecular pathways during diabesity.

Identifiants

pubmed: 35762558
pii: CPD-EPUB-124845
doi: 10.2174/1381612828666220628123224
doi:

Substances chimiques

Polyphenols 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1523-1542

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Muhammad Ajmal Shah (MA)

Department of Pharmacy, Hazara University, Mansehra, Pakistan.

Muhammad Haris (M)

Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.

Hafiza Ishmal Faheem (HI)

Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.

Ayesha Hamid (A)

Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.

Rimsha Yousaf (R)

Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.

Azhar Rasul (A)

Department of Zoology, Faculty of Life Sciences, Government College University, Faisalabad, Pakistan.

Ghulam Mujtaba Shah (GM)

Department of Pharmacy, Hazara University, Mansehra, Pakistan.
Department of Botany, Hazara University, Mansehra, Pakistan.

Atif Ali Khan Khalil (AAK)

Department of Biological Sciences, National University of Medical Sciences, Rawalpindi 46000, Pakistan.

Abdul Wahab (A)

Department of Pharmacy, Kohat University of Science & Technology, Kohat, Pakistan.

Haroon Khan (H)

Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan.

Reem Hasaballah Alhasani (RH)

Department of Biology, Faculty of Applied Science, Umm Al-Qura University, 21961 Makkah, Saudi Arabia.

Norah A Althobaiti (NA)

Department of Biology, College of Science and Humanities-Al Quwaiiyah, Shaqra University, Al Quwaiiyah, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH